Journal of Korean Neurosurgical Society
- 제30권1호
- /
- Pages.5-11
- /
- 2001
- /
- 2005-3711(pISSN)
- /
- 1598-7876(eISSN)
모야모야병에서 염기성 섬모 세포 성장 인자의 역할
The Role of Basic Fibroblast Growth Factor in Moyamoya Disease
- 김동석 (연세대학교 의과대학 신경외과학교실) ;
- 최중언 (연세대학교 의과대학 신경외과학교실) ;
- 김세혁 (연세대학교 의과대학 신경외과학교실) ;
- 양국희 (연세대학교 의과대학 신경외과학교실) ;
- 김현숙 (연세대학교 의과대학 임상병리학교실)
- Kim, Dong-Seok (Department of Neurosurgery, Brain Research Institute Yonsei University College of Medicine) ;
- Choi, Joong-Uhn (Department of Neurosurgery, Brain Research Institute Yonsei University College of Medicine) ;
- Kim, Se-Hyuk (Department of Neurosurgery, Brain Research Institute Yonsei University College of Medicine) ;
- Yang, Kook-Hee (Department of Neurosurgery, Brain Research Institute Yonsei University College of Medicine) ;
- Kim, Hyeun-Sook (Department of Clinical Pathology, Brain Research Institute Yonsei University College of Medicine)
- 투고 : 1999.12.03
- 심사 : 2000.08.16
- 발행 : 2001.01.28
초록
Objectives and Importance : The present study investigated the levels of basic fibroblast growth factor(bFGF) in the CSF of patients with moyamoya disease and its clinical significance. Methods : The levels of bFGF in CSF, taken from 26 hemispheres of 14 moyamoya patients and 20 patients without vascular anomaly(control group), were measured by an enzyme-linked immunosorbent assay. We analyzed the correlation between the level of bFGF and the clinical factors such as age, onset pattern, development of neovascularization, and cerebral circulation. Results : The CSF of moyamoya patients contained a high concentration of bFGF to a significant extent. The bFGF level was apparently elevated in the patients in whom neovascularization from indirect revascularization, such as modified encephalo-duro-arterio-synangiosis(EDAS) was well developed. A linear correlation between the values of bFGF and clinical progression was noted. Conclusions : The elevation of bFGF in moyamoya disease seems to be specific. Clinically, the bFGF level may be considered a useful indicator to predict the efficacy of indirect revascularization.
키워드